Qu’on peut aussi lire "J’ai assez d’emmerdes comme ça (pas dr majorité, un bilan nul, un avéir incertain, …) pour ne pas en plus risquer ma tête au bout d’une pique ! Mais si Attal y tient tant que ça, qu’il aille proposer la sienne !"
April 14, 2026 at 1:51 PM
Qu’on peut aussi lire "J’ai assez d’emmerdes comme ça (pas dr majorité, un bilan nul, un avéir incertain, …) pour ne pas en plus risquer ma tête au bout d’une pique ! Mais si Attal y tient tant que ça, qu’il aille proposer la sienne !"
Exodus Aveiro Fest. Festival de fotografia e vídeo está de regresso para mostrar novos projectos e culturas
comunidadeculturaearte.com/exodus-aveir...
comunidadeculturaearte.com/exodus-aveir...
Exodus Aveiro Fest. Festival de fotografia e vídeo está de regresso para mostrar novos projectos e culturas
A abordagem, através da imagem, a relevantes questões sociais e ambientais do planeta vai levar a Aveiro conceituados videógrafos e […]
comunidadeculturaearte.com
November 18, 2024 at 5:32 PM
Exodus Aveiro Fest. Festival de fotografia e vídeo está de regresso para mostrar novos projectos e culturas
comunidadeculturaearte.com/exodus-aveir...
comunidadeculturaearte.com/exodus-aveir...
Abbott Highlights New AVEIR™ Data, Initiates Trial for the Company's Conduction System Pacing Technology
Abbott Highlights New AVEIR™ Data, Initiates Trial for the Company's Conduction System Pacing Technology
Abbott Highlights New AVEIR™ Data, Initiates Trial for the Company's Conduction System Pacing Technology
Abbott Highlights New AVEIR™ Data, Initiates Trial for the Company's Conduction System Pacing Technology
Abbott Highlights New AVEIR™ Data, Initiates Trial for the Company's Conduction System Pacing Technology
todayscroll.com
April 27, 2025 at 6:41 PM
Abbott Highlights New AVEIR™ Data, Initiates Trial for the Company's Conduction System Pacing Technology
Abbott Highlights New AVEIR™ Data, Initiates Trial for the Company's Conduction System Pacing Technology
Abbott Highlights New AVEIR™ Data, Initiates Trial for the Company's Conduction System Pacing Technology
A abordagem, através da imagem, a relevantes questões sociais e ambientais do planeta vai levar a Aveiro conceituados videógrafos e fotógrafos internacionais, na sétima edição do festival Exodus, entre 29 de novembro e 01 de dezembro.
comunidadeculturaearte.com/exodus-aveir...
comunidadeculturaearte.com/exodus-aveir...
Exodus Aveiro Fest. Festival de fotografia e vídeo está de regresso para mostrar novos projectos e culturas
A abordagem, através da imagem, a relevantes questões sociais e ambientais do planeta vai levar a Aveiro conceituados videógrafos e […]
comunidadeculturaearte.com
November 28, 2024 at 4:31 PM
A abordagem, através da imagem, a relevantes questões sociais e ambientais do planeta vai levar a Aveiro conceituados videógrafos e fotógrafos internacionais, na sétima edição do festival Exodus, entre 29 de novembro e 01 de dezembro.
comunidadeculturaearte.com/exodus-aveir...
comunidadeculturaearte.com/exodus-aveir...
Pacemakers may offer a safer pacing option for solid organ transplant recipients at high infection risk. Early experience with the Aveir LP platform showed successful implantation, stable performance with no device-related infections during follow-up. tinyurl.com/yck2mnet
May 29, 2026 at 12:00 PM
Pacemakers may offer a safer pacing option for solid organ transplant recipients at high infection risk. Early experience with the Aveir LP platform showed successful implantation, stable performance with no device-related infections during follow-up. tinyurl.com/yck2mnet
Bir çocuğa implante edilen ilk kablosuz çift odacıklı kalp piline bir bakış.
AVEIR çift odacıklı cihazın geleneksel kalp pillerinden farkı, uçları veya kabloları olmaması ve geleneksel bir kalp pilinden 10 kat daha küçük.
Dahasını kardiyologlar okusun ve bizi bilgilendirsin👇
AVEIR çift odacıklı cihazın geleneksel kalp pillerinden farkı, uçları veya kabloları olmaması ve geleneksel bir kalp pilinden 10 kat daha küçük.
Dahasını kardiyologlar okusun ve bizi bilgilendirsin👇
First dual chamber leadless pacemaker implanted in a child
UC Davis pediatric cardiologist Dan Cortez is first in the world to implant a dual chamber leadless pacemaker in a child.
www.eurekalert.org
December 23, 2024 at 12:29 PM
Bir çocuğa implante edilen ilk kablosuz çift odacıklı kalp piline bir bakış.
AVEIR çift odacıklı cihazın geleneksel kalp pillerinden farkı, uçları veya kabloları olmaması ve geleneksel bir kalp pilinden 10 kat daha küçük.
Dahasını kardiyologlar okusun ve bizi bilgilendirsin👇
AVEIR çift odacıklı cihazın geleneksel kalp pillerinden farkı, uçları veya kabloları olmaması ve geleneksel bir kalp pilinden 10 kat daha küçük.
Dahasını kardiyologlar okusun ve bizi bilgilendirsin👇
“The AVEIR device is different from traditional #pacemakers in part because it has no leads or cords and is absorbed by the #heart. It is also 10 times smaller than a traditional #pacemaker": https://buff.ly/4iNKEvj #MedTwitter #cardiology
First dual chamber leadless pacemaker implanted in a child
Pediatric cardiologists have implanted a dual chamber leadless pacemaker in a child.
buff.ly
December 29, 2024 at 12:30 AM
“The AVEIR device is different from traditional #pacemakers in part because it has no leads or cords and is absorbed by the #heart. It is also 10 times smaller than a traditional #pacemaker": https://buff.ly/4iNKEvj #MedTwitter #cardiology
L’équipe du Pr David Cortez de l’université de Californie a réalisé l’implantation du pacemaker double chambre sans sonde Aveir chez une patiente de 13 ans.
Première mondiale : implantation d’un pacemaker de dernière génération chez une patiente de 13 ans
Commercialisé pour l’adulte aux États-Unis depuis 2023 et disponible en France dans quelques centres dans le cadre d’un Limited Market Release (LMR) depuis peu, le stimulateur cardiaque sans sonde à d...
www.lequotidiendumedecin.fr
December 24, 2024 at 3:14 PM
L’équipe du Pr David Cortez de l’université de Californie a réalisé l’implantation du pacemaker double chambre sans sonde Aveir chez une patiente de 13 ans.
✨ Exciting news
Last week, a 54-year-old lady (Karen Cooper) from Romsey in Southampton became the first patient at UHS to be fitted with ground-breaking dual-chamber pacemaker.
The revolutionary system (AVEIR DR) could transform care for thousands of patients with irregular rhythms. 💓
(1/2)
Last week, a 54-year-old lady (Karen Cooper) from Romsey in Southampton became the first patient at UHS to be fitted with ground-breaking dual-chamber pacemaker.
The revolutionary system (AVEIR DR) could transform care for thousands of patients with irregular rhythms. 💓
(1/2)
November 25, 2024 at 2:38 PM
✨ Exciting news
Last week, a 54-year-old lady (Karen Cooper) from Romsey in Southampton became the first patient at UHS to be fitted with ground-breaking dual-chamber pacemaker.
The revolutionary system (AVEIR DR) could transform care for thousands of patients with irregular rhythms. 💓
(1/2)
Last week, a 54-year-old lady (Karen Cooper) from Romsey in Southampton became the first patient at UHS to be fitted with ground-breaking dual-chamber pacemaker.
The revolutionary system (AVEIR DR) could transform care for thousands of patients with irregular rhythms. 💓
(1/2)
#ABT Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026
https://www.stocktitan.net/news/ABT/abbott-showcases-strength-of-its-technologies-to-address-abnormal-kve1rkglykl6.html
https://www.stocktitan.net/news/ABT/abbott-showcases-strength-of-its-technologies-to-address-abnormal-kve1rkglykl6.html
Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026
Abbott (NYSE: ABT) presented four late-breaking clinical datasets at Heart Rhythm Society 2026 showing positive outcomes for pulsed field ablation (PFA) and conduction system pacing (CSP) technologies.Key six-month and early follow-up results: TactiFlex Duo showed 87% arrhythmia-free and 98.3% safety in 188 patients; Volt PFA reported efficient treatment (4.1 applications per vein; 10.7 per PWI) with no procedure-related complications; CSP leads (UltiSynq and AVEIR) showed high implantation success, strong safety metrics, and stable early electrical performance.
www.stocktitan.net
April 25, 2026 at 4:30 PM
#ABT Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026
https://www.stocktitan.net/news/ABT/abbott-showcases-strength-of-its-technologies-to-address-abnormal-kve1rkglykl6.html
https://www.stocktitan.net/news/ABT/abbott-showcases-strength-of-its-technologies-to-address-abnormal-kve1rkglykl6.html
Abbott just trimmed 5.5 mm off its leadless pacemaker, a 14 percent shrink that could widen who qualifies for one. Abbott Wins FDA Approval for Aveir VR Mini, Its Smallest Leadless Pacemaker Yet
September 16, 2026 at 1:29 PM
Abbott just trimmed 5.5 mm off its leadless pacemaker, a 14 percent shrink that could widen who qualifies for one. Abbott Wins FDA Approval for Aveir VR Mini, Its Smallest Leadless Pacemaker Yet
de novo, Aveiro perdeu
de novo, os Aveirenses perderam
Sem reconhecimento de peso político, pensar Aveiro sem uma ideia é inócuo e naïf.
debaixodosarcos.blogs.sapo.pt/pensar-aveir...
de novo, os Aveirenses perderam
Sem reconhecimento de peso político, pensar Aveiro sem uma ideia é inócuo e naïf.
debaixodosarcos.blogs.sapo.pt/pensar-aveir...
Pensar Aveiro não pode ser Desvalorizar Aveiro
Não havendo a travessia da Ria para São Jacinto para anunciar (bem ou mal, ao menos seria uma ideia, um projeto, um plano… já que nada mais há) esperava poder ser mais concreto e pragmática na respost...
debaixodosarcos.blogs.sapo.pt
March 16, 2025 at 11:19 AM
de novo, Aveiro perdeu
de novo, os Aveirenses perderam
Sem reconhecimento de peso político, pensar Aveiro sem uma ideia é inócuo e naïf.
debaixodosarcos.blogs.sapo.pt/pensar-aveir...
de novo, os Aveirenses perderam
Sem reconhecimento de peso político, pensar Aveiro sem uma ideia é inócuo e naïf.
debaixodosarcos.blogs.sapo.pt/pensar-aveir...
Salvan a una bebé de 2,1 kilos con un marcapasos de 2 cm #SantJoanDeDeu #Barcelona #CardiologiaPediatrica #Neonatologia #Marcapasos #Salud #Ciencia #TecnologiaMedica #Abbott #AVEIR #Medicina #Investigacion #4demarzo #miercoles #España donporque.com/salvan-bebe-...
Salvan a una bebé de 2,1 kilos con un marcapasos de 2 cm
En Sant Joan de Déu implantan un marcapasos de 2cm a una recién nacida de 2,1 kilos y cuentan a fondo la cirugía que evitó el fallo cardíaco. En el Hospital Sant Joan de Déu de Barcelona, una recién n...
donporque.com
March 4, 2026 at 2:34 PM
Salvan a una bebé de 2,1 kilos con un marcapasos de 2 cm #SantJoanDeDeu #Barcelona #CardiologiaPediatrica #Neonatologia #Marcapasos #Salud #Ciencia #TecnologiaMedica #Abbott #AVEIR #Medicina #Investigacion #4demarzo #miercoles #España donporque.com/salvan-bebe-...
New from me: The FDA approved Abbott's new dual-chamber, leadless pacemaker, which showed good safety and efficacy in clinical trials.
https://www.forbes.com/sites/alexknapp/2023/07/05/fda-gives-the-okay-for-abbotts-new-minimally-invasive-pacemaker/
https://www.forbes.com/sites/alexknapp/2023/07/05/fda-gives-the-okay-for-abbotts-new-minimally-invasive-pacemaker/
FDA Gives The Okay For Abbott’s New Minimally Invasive Pacemaker
Medtech giant Abbott announced that its new leadless pacemaker system, Aveir DR, has been approved by the FDA.
www.forbes.com
July 5, 2023 at 2:03 PM
New from me: The FDA approved Abbott's new dual-chamber, leadless pacemaker, which showed good safety and efficacy in clinical trials.
https://www.forbes.com/sites/alexknapp/2023/07/05/fda-gives-the-okay-for-abbotts-new-minimally-invasive-pacemaker/
https://www.forbes.com/sites/alexknapp/2023/07/05/fda-gives-the-okay-for-abbotts-new-minimally-invasive-pacemaker/
Avis relatif à la tarification du stimulateur cardiaque ventriculaire implantable simple chambre sans sonde, implanté par voie transcathéter AVEIR visé à l’article L. 165-1 du code de la sécurité sociale
En application de la convention entre le comité économique des produits de santé et la société…
En application de la convention entre le comité économique des produits de santé et la société…
Avis relatif à la tarification du stimulateur cardiaque ventriculaire implantable simple chambre sans sonde, implanté par voie transcathéter AVEIR visé à l’article L. 165-1 du code de la sécurité sociale
En application de la convention entre le comité économique des produits de santé et la société ABBOTT MEDICAL France, le tarif et le prix limite de vente au public en € TTC (PLV) du produit visé ci-dessous sont fixés comme suit et prennent effet à compter du treizième jour suivant la date de la publication du présent avis au Journal officiel de la République française : CODE DÉSIGNATION Tarif en € TTC PLV
kohenavocats.fr
December 25, 2024 at 4:28 AM
Avis relatif à la tarification du stimulateur cardiaque ventriculaire implantable simple chambre sans sonde, implanté par voie transcathéter AVEIR visé à l’article L. 165-1 du code de la sécurité sociale
En application de la convention entre le comité économique des produits de santé et la société…
En application de la convention entre le comité économique des produits de santé et la société…
Arrêté du 2 juillet 2024 portant inscription du stimulateur cardiaque ventriculaire implantable simple chambre sans sonde implanté par voie transcathéter AVEIR de la société ABBOTT MEDICAL France au titre III de la liste des produits et prestations remboursables prévue à l’article L. 165-1 du code…
Arrêté du 2 juillet 2024 portant inscription du stimulateur cardiaque ventriculaire implantable simple chambre sans sonde implanté par voie transcathéter AVEIR de la société ABBOTT MEDICAL France au titre III de la liste des produits et prestations remboursables prévue à l’article L. 165-1 du code de la sécurité sociale
Au titre III de la liste des produits et prestations remboursables, chapitre 4, section 1, dans la sous-section 3 « Stimulateurs cardiaques implantables simple chambre implantés par voie transcathéter », est ajoutée la rubrique suivante : CODE NOMENCLATURE ABBOTT MEDICAL France (ABBOTT) 3423942 Stimulateur cardiaque simple chambre, transcatheter, ABBOTT, AVEIR.
kohenavocats.fr
December 25, 2024 at 4:10 AM
Arrêté du 2 juillet 2024 portant inscription du stimulateur cardiaque ventriculaire implantable simple chambre sans sonde implanté par voie transcathéter AVEIR de la société ABBOTT MEDICAL France au titre III de la liste des produits et prestations remboursables prévue à l’article L. 165-1 du code…
Abbott’s Aveir CSP Leadless Pacemaker Evaluated in Acute Clinical Feasibility Study
Abbott’s Aveir CSP Leadless Pacemaker Evaluated in Acute Clinical Feasibility Study - Cardiac Interventions Today
April 27, 2025—Abbott announced late-breaking data from the AVEIR conduction system pacing (CSP) acute clinical feasibility study, which demonst
citoday.com
April 29, 2025 at 1:52 PM
Abbott’s Aveir CSP Leadless Pacemaker Evaluated in Acute Clinical Feasibility Study
Abbott Launches Clinical Trial for Revolutionary AVEIR Conduction System Pacing Technology#United_States#San_Diego#Abbott#AVEIR#Conduction_System
Abbott Launches Clinical Trial for Revolutionary AVEIR Conduction System Pacing Technology
Abbott has announced the initiation of a pivotal trial for its new AVEIR Conduction System Pacing technology, showcasing its innovative leadless pacemaker.
third-news.com
April 27, 2025 at 6:17 PM
Abbott Launches Clinical Trial for Revolutionary AVEIR Conduction System Pacing Technology#United_States#San_Diego#Abbott#AVEIR#Conduction_System
Technological advance in my area - £600 vitatron pacemaker, £6000 micra leadless pacemaker, £16000 Aveir dual chamber leadless pacemaker. (Approx costs to nhs of device)
March 16, 2025 at 8:59 AM
Technological advance in my area - £600 vitatron pacemaker, £6000 micra leadless pacemaker, £16000 Aveir dual chamber leadless pacemaker. (Approx costs to nhs of device)